Patents by Inventor Sean Lilienfeld

Sean Lilienfeld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7351253
    Abstract: A method of treating Alzheimer's Disease in which intranasal red light devices are used to shine red light upon the brain structures.
    Type: Grant
    Filed: June 16, 2005
    Date of Patent: April 1, 2008
    Assignee: Codman & Shurtleff, Inc.
    Inventors: Thomas M. DiMauro, Mohamed Attawia, Sean Lilienfeld, Chantal Holy
  • Publication number: 20080014152
    Abstract: The intranasal delivery of an effective amount of NGF inducers, such as clenbuterol, to the brain.
    Type: Application
    Filed: July 13, 2006
    Publication date: January 17, 2008
    Inventors: Thomas M. Di Mauro, Chantal Holy, Mohamed Attawia, Sean Lilienfeld, Terri Kapur, Francis Binette
  • Publication number: 20080014176
    Abstract: UVB irradiation of white blood cells in order to induce tolerance to antigenic ?AP 1-42. To treat Alzheimer's Disease in a patient, irradiate autologous white blood cells with UVB light to cause tolerance therein. Combine the tolerized cells with ?AP 1-42 to form a mixture. To treat stroke or multiple sclerosis in a patient, irradiate autologous white blood cells with UVB light to cause tolerance therein. Combine the tolerized cells with myelin basic protein to form a mixture.
    Type: Application
    Filed: July 17, 2006
    Publication date: January 17, 2008
    Inventors: Thomas M. Di Mauro, Chantal Holy, Mohamed Attawia, Sean Lilienfeld
  • Publication number: 20080014285
    Abstract: A method of treating brain injury involving intrathecally administering a composite powder comprising superparamagentic nanoparticle and a therapeutic agent compound, and then magnetically transporting the composite into an injured brain.
    Type: Application
    Filed: July 13, 2006
    Publication date: January 17, 2008
    Inventors: Thomas M. Di Mauro, Sean Lilienfeld, Mohamed Attawia
  • Patent number: 7288108
    Abstract: This invention relates to an implantable device that delivers an effective amounts of red light to the substantia nigra as a treatment for Parkinson's Disease (PD).
    Type: Grant
    Filed: March 14, 2005
    Date of Patent: October 30, 2007
    Assignee: Codman & Shurtleff, Inc.
    Inventors: Thomas M. DiMauro, Mohamed Attawia, Chantal Holy, Sean Lilienfeld, Jeffrey K. Sutton, Michael Ward
  • Publication number: 20070239235
    Abstract: This invention relates to an implantable device that delivers an effective amounts of red light to the substantia nigra as a treatment for Parkinson's Disease (PD).
    Type: Application
    Filed: June 12, 2007
    Publication date: October 11, 2007
    Inventors: Thomas DiMauro, Mohamed Attawia, Chantal Holy, Sean Lilienfeld, Jeffrey Sutton, Michael Ward
  • Publication number: 20070031341
    Abstract: Intranasal iontophoretic administration of therapeutics such as Reduced Water (RW) or lubeluzole as a means of treating diseases of the CNS involving oxidative stress.
    Type: Application
    Filed: August 8, 2005
    Publication date: February 8, 2007
    Inventors: Thomas DiMauro, Mohamed Attawia, Richard Toselli, Sean Lilienfeld
  • Publication number: 20070010859
    Abstract: Co-administration of an effective amount of autoantigen and UV light to mucosal associated lymphatic tissue (MALT) in a patient.
    Type: Application
    Filed: July 7, 2005
    Publication date: January 11, 2007
    Inventors: Thomas DiMauro, Mohamed Attawia, Sean Lilienfeld, Chantal Holy, Michael Montgomery
  • Publication number: 20060287695
    Abstract: A method of treating Alzheimer's Disease in which intranasal red light devices are used to shine red light upon the brain structures.
    Type: Application
    Filed: June 16, 2005
    Publication date: December 21, 2006
    Inventors: Thomas DiMauro, Mohamed Attawia, Sean Lilienfeld, Chantal Holy
  • Publication number: 20060269525
    Abstract: This invention relates to a graft for treating Parkinson's Disease, wherein, in one embodiment, the graft contains an effective amount of both a) adrenal chromaffin cells (ACCs), and b) olfactory ensheathing cells (OECs), and GDF-5.
    Type: Application
    Filed: May 25, 2005
    Publication date: November 30, 2006
    Inventors: Sean Lilienfeld, Thomas DiMauro, Mohamed Attawia, Chantal Holy
  • Publication number: 20060224185
    Abstract: Heating the hypothalamus, preferably by ultrasound, to cause the release of ?MSH in the brain.
    Type: Application
    Filed: March 31, 2005
    Publication date: October 5, 2006
    Inventors: Thomas DiMauro, Mohamed Attawia, Sean Lilienfeld
  • Publication number: 20060206172
    Abstract: This invention relates to an implantable device that delivers an effective amounts of red light to the substantia nigra as a treatment for Parkinson's Disease (PD).
    Type: Application
    Filed: March 14, 2005
    Publication date: September 14, 2006
    Inventors: Thomas DiMauro, Mohamed Attawia, Chantal Holy, Sean Lilienfeld, Jeffrey Sutton, Michael Ward
  • Publication number: 20060100679
    Abstract: An intracranial, light-emitting implant for providing therapy to a patient having Alzheimer's Disease.
    Type: Application
    Filed: August 29, 2005
    Publication date: May 11, 2006
    Inventors: Thomas DiMauro, Mohamed Attawia, Sean Lilienfeld, Chantal Holy, Jeffrey Sutton, Michael Ward
  • Publication number: 20050222122
    Abstract: The present invention relates to a method of treating dementia or a memory disorder comprising administration of a therapeutically effective amount of galantamine (I) and a statin (II). The invention further relates to products containing as first active ingredient galantamine (I) and as second active ingredient a statin (II), as combined preparations for simultaneous, separate or sequential use in the treatment of patients suffering from Alzheimer's disease or related dementias; to related pharmaceutical compositions and uses.
    Type: Application
    Filed: March 28, 2003
    Publication date: October 6, 2005
    Inventors: Sean Lilienfeld, Elane Gutterman, Royston Glasspool